PIPELINE
PRODUCT DEVELOPMENT
A Generics For Popular Opioid Addiction
More than 27 million people suffer from opioids use disorder globally, many would seek medical help to relief their withdrawal symptom during cessation. While medical opioid replacement was prescribed to assist this procedure, it is crucial to keep the patient from harm in using external opioids and avoid unauthorized diversion of the medicine.
Benefiting from TAHO's expertise in transmucosal delivery, our scientists had stepped up to address this global pandemic of drug misuse. By offering this anti-opioid dependence treatment, we teamed up with global pharmaceutical companies to promote widespread and easy access to safe opioid cessation.